Lipid replacement/antioxidant therapy as an adjunct supplement to reduce the adverse effects of cancer therapy and restore mitochondrial function

Pathology and Oncology Research

Volumn 11, Issue 3, 2005, Pages 139-144

  Nicolson, Garth L ^a  

^a INSTITUTE FOR MOLECULAR MEDICINE   (United States)

Author keywords

Antioxidants; Cancer therapy; Dietary supplement; Fatigue; Lipids; Mitochondria

Indexed keywords

ANTIOXIDANT; GLYCOPHOSPHOLIPID; LIPID; PLACEBO; PROBIOTIC AGENT; REACTIVE OXYGEN METABOLITE; VITAMIN;

AGING; ARTICLE; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER THERAPY; CHRONIC FATIGUE SYNDROME; DIARRHEA; DIET SUPPLEMENTATION; FATIGUE; HEADACHE; HUMAN; MALAISE; MITOCHONDRION; NAUSEA; OXIDATIVE STRESS; QUALITY OF LIFE; RESPIRATORY CHAIN; SYSTEMATIC REVIEW; TISSUE INJURY; VOMITING;

EID: 27644475899     PISSN: 12194956     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02893390     Document Type: Article

References (49)

1. Buckingham R, Fitt J, Sitzia J: Patients' experience of chemotherapy: side-effects of carboplatin in the treatment of carcinoma of the ovary. Eur J Cancer Care 6: 59-71, 1997.
2. Vogelzang N, Breitbart W, Cella D, et al: Patient caregiver and oncologist perceptions of cancer-related fatigue: results of a tripart assessment survey. Semin Hematol 34 (Suppl 2): 4-12, 1997.
3. Romanelli A, Bozzone A, Magrone G, et al: Cancer-related fatigue: evaluation and treatment. Rays 29: 453-455, 2004.
4. Bender CM, Ergyn FS, Rosenzweig MQ, et al: Symptom clusters in breast cancer across 3 phases of the disease. Cancer Nurs 28: 219-225, 2005.
5. Ahlberg K, Ekman T, Gaston-Johansson F: Fatigue, psychological distress, coping resources, and functional status during radiotherapy for uterine cancer. Oncol Nurs Forum 32: 633-640, 2005.
6. Shafqat A, Einhorn LH, Hanna N, et al: Screening studies for fatigue and laboratory correlates in cancer patients undergoing treatment (dagger). Ann Oncol 16: 1545-1550, 2005.
7. Liu L, Marler MR, Parker BA, et al: The relationship between fatigue and light exposure during chemotherapy. Support Care Cancer in press, 2005.
8. Von Roenn JH, Paice JA: Control of common, non-pain cancer symptoms. Semin Oncol 32: 200-210, 2005.
9. Kroenke K, Wood DR, Mangelsdorff AD, et at: Chronic fatigue in primary care. Prevalence, patient characteristics, and outcome. JAMA 260: 929-934, 1988.
10. Morrison JD: Fatigue as a presenting complaint in family practice. J Family Pract 10: 795-801, 1980.
11. McDonald E, David AS, Pelosi AJ, Mann AH: Chronic fatigue in primary care attendees. Psychol Med 23:987-998, 1993.
12. Piper BF, Linsey AM, Dodd MJ: Fatigue mechanism in cancer. Oncol Nursing Forum 14: 17-23, 1987.
13. Piper BF, Dribble SL, Dodd MJ, et al: The revised Piper Fatigue Scale: psychometric evaluation in women with breast cancer. Oncol Nursing Forum 25: 667-684, 1998.
14. Nicolson GL: Lipid replacement as an adjunct to therapy for chronic fatigue, anti-aging and restoration of mitochondrial function. J Am Nutraceut Assoc 6: 22-28, 2003.
15. Huang H, Manton KG: The role of oxidative damage in mitochondria during aging: a review. Front Biosci 9: 1100-1117, 2004.
16. Richter C, Par JW, Ames B: Normal oxidative damage to mitochondrial and nuclear DNA is extensive. Proc Natl Acad Sci USA 85: 6465-6467, 1998.
17. Wei YH, Lee HC: Oxidative stress, mitochondrial DNA mutation and impairment of antioxidant enzymes in aging. Exp Biol Med 227: 671-682, 2002.
18. Harman D: Aging: A theory based on free radical and radiation chemistry. J Gerontol 2: 298-300, 1956.
19. Halliwell B: Role of free radicals in the neurodegenerative diseases: therapeutic implications for antioxidant treatment. Drugs Aging 18: 685-716, 2001.
20. Tan NSS, Vinckenbosch NS, Liu N, et al: Selective cooperation between fatty acid binding proteins and peroxisome proliferator-activated receptors in regulating transcription. Mol Cell Biol 22: 5114-5127, 2002.
21. Chen D, Cao G, Hastings T, et al: Age-dependent decline of DNA repair activity for oxidative lesions in rat brain mitochondria. J Neurochem 81: 1273-1284, 2002.
22. Xu D, Finkel T: A role for mitochondria as potential regulators of cellular life span. Biochem Biophys Res Commun 294: 245-248, 2002.
23. Logan AC, Wong C: Chronic fatigue syndrome: oxidative stress and dietary modifications. Altern Med Rev 6: 450-459, 2001.
24. Manuel y Keenoy B, Moorkens G, Vertommen J, et al: Antioxidant status and lipoprotein peroxidation in chronic fatigue syndrome. Life Sci 68: 2037-2049, 2001.
25. Richards RS, Roberts TK, McGregor NR, et al: Blood parameters indicative of oxidative stress are associated with symptom expression in chronic fatigue syndrome. Redox Rep 5: 35-41, 2000.
26. Felle S, Mecocci P, Fano G, et al: Specific oxidative alterations in vastus lateralis muscle of patients with the diagnosis of chronic fatigue syndrome. Free Radical Biol Med 29: 1252-1259, 2000.
27. Pall ML: Elevated, sustained peroxynitrite levels as the cause of chronic fatigue syndrome. Med Hypotheses 54: 115-125, 2000.
28. Castro L, Rodriguez M, Radi R: Aconitase is readily inactivated by peroxynitrite, but not by its precursor, nitric oxide. J Biol Chem 269: 29409-29415, 1994.
29. Radi R, Rodriguez M, Castro L, Telleri R: Inhibition of mitochondrial electronic transport by peroxynitrite. Arch Biochem Biophys 308: 89-95, 1994.
30. Manuel y Keenoy B, Moorkens G, Vertommen J, et et al: Magnesium status and parameters of the oxidant-antioxidant balance in patients with chronic fatigue: effects of supplementation with magnesium. J Am Coll Nutr 19: 374-382, 2000.
31. Kanno T, Satto EE, Muranaka S, et al: Oxidative stress underlies the mechanism for Ca(2+)-induced permeability transition of mitochondria. Free Radical Res 38: 27-35, 2004.
32. Nicolson GL, Poste G, Ji T: Dynamic aspects of cell membrane organization. Cell Surface Rev 3: 1-73, 1977.
33. Subczynski WK, Wisniewska A: Physical properties of lipid bilayer membranes: relevance to membrane biological functions. Acta Biochim Pol 47: 613-625, 2000.
34. Ellithorpe RR, Settineri R, Nicolson GL: Reduction of fatigue by use of a dietary supplement containing glycophospholipids. J Am Nutraceut Assoc 6: 23-28, 2003.
35. Agadjanyan M, Vasilevko V Ghochikyan A, et al: Nutritional supplement (NTFactor) restores mitochondrial function and reduces moderately severe fatigue in aged subjects. J Chronic Fatigue Syndr 11: 23-26, 2003.
36. Hajri T, Abumrad NA: Fatty acid transport across membranes: relevance to nutrition and metabolic pathology. Annu Rev Nutr 22: 383-415, 2002.
37. Hamilton JA: Fatty acid transport: difficult or easy? J Lipid Res 39:467-481, 1998.
38. Fellmann P, Herve P, Pomorski T, et al: Transmembrane movement of diether phospholipids in human erythrocytes and human fibroblasts. Biochemistry 39: 4994-5003, 2000.
39. Conner SD, Schmid SL: Regulated portals of entry into the cell. Nature 422: 37-44, 2003.
40. Mansbach CM, Dowell R: Effect of increasing lipid loads on the ability of the endoplasmic reticulum to transport lipid to the Golgi. J Lipid Res 41: 605-012, 2000.
41. De AK, Darad R: Age-associated changes in antioxidants and antioxidative enzymes in rats. Mech Ageing Dev 59: 123-128, 1991.
42. Ames BM: Micronutrients prevent cancer and delay aging. Toxicol Lett 102: 1035-1038, 1998.
43. Sharman EH, Bondy SC: Effects of age and dietary antioxidants on cerebral electron transport chain activity. Neurobiol Aging 22: 629-634, 2001.
44. Sugiyama S, Yamada K, Ozawa T: Preservation of mitochondrial respiratory function by coenzyme Q10 in aged rat skeletal muscle. Biochem Mol Biol Int 37: 1111-1120, 1995.
45. Lin MT, Simon DK, Ahn CH, et al: High aggregate burden of somatic mtDNA point mutations in aging and Alzheimer's disease brain. Hum Mol Genet 11: 133-145, 2002.
46. Seidman M, Khan MJ, Tang WX, Quirk WS: Influence of lecithin on mitochondrial DNA and age-related hearing loss. Otolaryngol Head Neck Surg 127: 138-144, 2002.
47. Miguel J: Can antioxidant diet supplementation protect against age-related mitochondrial damage? Ann NY Acad Sci 959: 317-347, 2002.
48. Nicolson GL, Ellithorpe R: Lipid replacement and antioxidant nutritional therapy for restoring mitochondrial function and reducing fatigue in chronic fatigue syndrome and other fatiguing illnesses. J Chronic Fatigue Syndr, in press, 2005.
49. Colodny L, Lynch K, Farber C, et al: Results of a study to evaluate the use of Propax to reduce adverse effects of chemotherapy. J Am Nutraceut Assoc 2: 17-25, 2000.